PATHFINDER 2 study: multi-cancer test performance under review

University of Basel research on early cancer detection test

University of Basel conducted a study assessing the performance and safety of a multi-cancer early detection test called PATHFINDER 2. The research focuses on technical metrics for early cancer identification. While the source description notes potential for earlier treatment access, no specific mortality reduction claims, test accuracy figures, or clinical trial results are available here. Since the source material is unreachable, we cannot verify the study's current findings or real-world impact. This signal remains in early research stages with no published results to assess. The detail sits with the source.

Source: Nature Medicine